GB Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GB Sciences generated cash of -$975,698, which is more than the previous year. Cash used in financing activities reached the amount of $557,777 last year. Net change in cash is therefore -$97,921.
Cash Flow
| 2012 | -96.51K | 0 | 51K |
|---|---|---|---|
| 2016 | -3.56M | -859.13K | 4.45M |
| 2018 | -12.24M | -5.40M | 18.53M |
| 2020 | -4.47M | -538.78K | 4.98M |
| 2021 | -2.18M | 4.65M | -1.47M |
| 2023 | -1.52M | -31.65K | 1.43M |
| 2024 | -975.69K | 320K | 557.77K |
GBLX Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 109.91K | 233.89K | 151.76K | 182.05K | 2.69M | 0 | 47.69K |
Operating activities | |||||||
Net income | -1.36M | -4.12M | -4.11M | -11.63M | -23.15M | -7.07M | -14.76K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 624 | 61.66K | 47.35K | 258.72K | 804.78K | 177.12K | 207 |
Stock-based compensation expense | 219.16K | 17.33K | 436.34K | 287.26K | 7.22M | 1.82M | 0 |
| Deferred income tax benefit | 219.16K | 17.33K | 436.34K | 287.26K | 7.22M | 1.82M | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 412.49K | -741 | -17.86K | 0 |
Inventories | 0 | 0 | 0 | 665.56K | -960 | 2.89M | 0 |
Accounts payable | 157.59K | -20.19K | -248.11K | 781.58K | 975.59K | 641.37K | 6.19K |
Cash generated by operating activities | -975.69K | -1.52M | -2.18M | -4.47M | -12.24M | -3.56M | -96.51K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -31.65K | -292.67K | -294.15K | -3.42M | -881.59K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 3.12M | 480K | 0 |
Cash generated by investing activities | 320K | -31.65K | 4.65M | -538.78K | -5.40M | -859.13K | 0 |
Financing activities | |||||||
Common Stock Issued | 235.77K | 1.48M | 1.07M | 790.22K | 7.2M | 1.47M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 322K | -48.82K | -3.30M | 3.00M | 8.21M | 2.20M | 0 |
Cash used in financing activities | 557.77K | 1.43M | -1.47M | 4.98M | 18.53M | 4.45M | 51K |
Net Change In Cash | -97.92K | -123.98K | 641.27K | -30.28K | 886.74K | 34.82K | -45.51K |
Cash at end of period | 11.99K | 109.91K | 793.04K | 151.76K | 3.57M | 34.82K | 2.17K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |